Jones GABA Set to Hit Shelves in 2009
Jones Soda Co. [[JSDA]] was recently moved from the OTC-BB to the Nasdaq Stock Exchange and the move has been paying big dividends. Shares moved sharply higher after the company announced its highly anticipated tea-juice blend with amino acid. GABA will be available in stores across the country in early spring 2009 as the only beverage in the United States with PharmaGABA, which studies have shown to improve mental focus, balance and clarity, while reducing stress.
“Jones GABA is a revolutionary, great-tasting beverage,” said Joth Ricci, Chief Executive of Jones Soda. “It has a rare distinction in the functional beverage marketplace. Its benefits can be felt within five minutes and have been shown to last for hours. Jones GABA helps people feel more relaxed and focused, allowing them to perform at their peak.”
GABA (gamma-aminobutyric acid) has become extremely popular in Japan as a functional food and beverage ingredient and is expected to achieve mainstream popularity in the U.S. PharmaGABA is the natural form of GABA, a key neurotransmitter in the regulation of proper brain functionality. In Japan, sales of GABA-infused food and beverages increased more than five-fold between 2004 and 2006, with 2006 sales reaching approximately $122 million. (“Japanese Health Food and Component Markets,” Japanese World, September 8, 2006.)
“There is a lot of great science to support the effectiveness of PharmaGABA,” said Dr. Michael Murray, a leading expert on natural medicine. “PharmaGABA has been shown to counteract the effects of stress on both the mind and body. It increases the production of alpha waves in the brain as well as reduces biological markers of stress like cortisol levels. The benefits of PharmaGABA’s anti-stress effects are quite apparent in that it induces feelings of calmness and clarity, creating increased focus on the task at hand, which is very unique.”
Investors can find more information about Jones GABA on their web site JonesGABA.com.
CONTACT: 888-288-5215 · Please read our Full Disclaimer pertaining to this article.